Priority 23 from the Mesothelioma PSP
| UNCERTAINTY: Is there an overall benefit for standard chemotherapy in terms of QALYS (Quality Adjusted Life Years, a measurement that combines survival and quality of life) compared to supportive care alone, for mesothelioma patients? (JLA PSP Priority 23) | |
|---|---|
| Overall ranking | 23 |
| JLA question ID | 0025/23 |
| Explanatory note | Not available for this PSP |
| Evidence | No systematic reviews or studies identified |
| Health Research Classification System category | Cancer |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | Treatment needs to be as quick as possible to maximise the patients quality of life within the short time span available ~ To what extent is the Quality of Life issue measured against the effects of chemotherapy for terminal patients? ~ The effects [from chemo] on quality of life were so terrible that - [perhaps] if he might have had a little less time, but better quality, if he had declined chemotherapy ~ Chemo-radiotherapy I believe makes quality of life for patients after treatment poor |
| Comparison | None identified |
| Submitted by | Bereaved x 3 ~ Health Professional |
| Outcomes to be measured | QALYs (Quality Adjusted Life Years) |
| PSP information | |
|---|---|
| PSP unique ID | 0025 |
| PSP name | Mesothelioma |
| Total number of uncertainties identified by this PSP. | 53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 16 December 2014 |